Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pycnogenol - Nutraceuticals World
Research

Pycnogenol

Indication: Asthma

Source: J Asthma, 2004;41(8):825-32.

Research: A randomized, placebo-controlled, double-blind study involving 60 subjects, aged 6-18 years, was conducted over a period of three months to determine the effect of Pycnogenol (a proprietary mixture of water-soluble bio­flavonoids extracted from French maritime pine) on mild-to-moderate asthma. After baseline evaluation, subjects were randomized into two groups to receive either Pycnogenol or placebo. Subjects were instructed to record their peak expiratory flow with an Assess Peak Flow Meter each evening. At the same time, symptoms, daily use of rescue inhalers (albuterol) and any changes in oral medications were also recorded. Urine samples were obtained from the subjects at the end of the run-in period, and at one-, two-, and three-month visits.

Results: Compared with subjects taking placebo, the group that took Pycnogenol had significantly more improvement in pulmonary functions and asthma symptoms. The Pycnogenol group was able to reduce or discontinue their use of rescue inhalers more often than the placebo group. Researchers concluded that Pycnogenol could be used as an adjunct in the management of mild-to-moderate childhood asthma.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters